| Trial name or title |
Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at‐risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double‐blind, placebo‐controlled clinical trial (HARPOON study) |
| Methods |
Randomised controlled trial |
| Participants |
390 patients aged 70 years and older admitted through the emergency department for general medicine and surgical specialties |
| Interventions |
Prophylactic haloperidol 1 mg or placebo twice daily for seven days |
| Outcomes |
Incidence of delirium, severity of delirium, duration of delirium, adverse events, length of stay, all cause mortality, institutionalisation, instrumental ADL, cognitive function |
| Starting date |
TBC |
| Contact information |
Edmee Schrijver. ej.schrijver@vumc.nl |
| Notes |
ClinicalTrials.gov identifier NCT01530308
|
